Sangamo Therapeutics (SGMOQ) Prepaid Assets (2010 - 2025)
Sangamo Therapeutics (SGMOQ) posted Prepaid Assets of $4.4 million for Q4 2025, down 48.13% on a QoQ basis from $8.4 million in Q3 2025, and down 15.57% year-over-year from $5.2 million in Q4 2024.
Analysis
Sangamo Therapeutics (SGMOQ) Prepaid Assets (2010 - 2025) Analysis & Trends
Sangamo Therapeutics has reported Prepaid Assets for 16 years, with the latest figure at $4.4 million in Q4 2025.
- On a quarterly basis, Prepaid Assets fell 15.57% year-over-year to $4.4 million in Q4 2025; TTM through Dec 2025 was $4.4 million, a 15.57% decrease from a year earlier, with the FY2025 full-year figure at $4.4 million, down 15.57% from the prior year.
- Prepaid Assets was $4.4 million for Q4 2025 at Sangamo Therapeutics, down from $8.4 million in the prior quarter.
- The five-year high for Prepaid Assets was $21.1 million in Q2 2022, with the low at $4.4 million in Q4 2025.
- Average Prepaid Assets over 5 years is $12.3 million, with a median of $12.6 million recorded in 2023.
- The sharpest annual moves came in 2021 and 2023: Prepaid Assets soared 146.65% in 2021, then tumbled 49.19% in 2023.
- Over 5 years, Prepaid Assets stood at $15.9 million in 2021, then gained by 14.91% to $18.2 million in 2022, then plunged by 49.19% to $9.3 million in 2023, then plunged by 44.11% to $5.2 million in 2024, then decreased by 15.57% to $4.4 million in 2025.
- The last three Prepaid Assets figures came in at $4.4 million (Q4 2025), $8.4 million (Q3 2025), and $6.6 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.42 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - |
| 3 | Iovance Biotherapeutics | 3.78 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.06 Bn | 3.06 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.68 Bn | 2.68 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.35 Bn | 1.55 Bn | 251.87 Mn |
| 9 | Vericel | 2.00 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 4.37 Mn |
| Sep 30, 2025 | 8.42 Mn |
| Jun 30, 2025 | 6.57 Mn |
| Mar 31, 2025 | 7.81 Mn |
| Dec 31, 2024 | 5.18 Mn |
| Sep 30, 2024 | 8.43 Mn |
| Jun 30, 2024 | 11.71 Mn |
| Mar 31, 2024 | 12.61 Mn |
| Dec 31, 2023 | 9.26 Mn |
| Sep 30, 2023 | 13.72 Mn |
| Jun 30, 2023 | 12.57 Mn |
| Mar 31, 2023 | 13.65 Mn |
| Dec 31, 2022 | 18.22 Mn |
| Sep 30, 2022 | 18.01 Mn |
| Jun 30, 2022 | 21.11 Mn |
| Mar 31, 2022 | 14.98 Mn |
| Dec 31, 2021 | 15.86 Mn |
| Sep 30, 2021 | 15.40 Mn |
| Jun 30, 2021 | 16.72 Mn |
| Mar 31, 2021 | 12.14 Mn |